Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,364 public trials 2,842 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes

NCT04802161

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, Acute Myeloid Leukemia With Multilineage Dysplasia, +19 more
Locations
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Realizing Effectiveness Across Continents With Hydroxyurea (REACH)

NCT01966731

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Hospital Pediátrico David Bernardino Luanda, Angola
  • Centre Hospitalier Monkole Kinshasa, Democratic Republic of the Congo
  • KEMRI/Wellcome Trust Research Kilifi, Kenya
  • Ministry of Health Mbale Regional Hospital Mbale, Uganda
View Trial Details
Active, Not Recruiting

Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation

NCT03173248

Conditions
AML Arising From Myelodysplastic Syndrome (MDS), Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Norton Cancer Institute - Suburban Louisville, Kentucky, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
View all 90 locations
View Trial Details
Active, Not Recruiting

A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks

NCT06851559

Conditions
Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
Locations
  • Preferred Research Partners, Inc Little Rock, Arkansas, United States
  • GW Research, Inc Chula Vista, California, United States
  • Southern California Research Institute Medical Group Los Angeles, California, United States
  • Rocky Mountain Gastroenterology Lakewood, Colorado, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia

NCT02724163

Conditions
Acute Myeloid Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Women and Children's Hospital Adelaide Adelaide, Australia
  • Queensland Children's Hospital Brisbane, Australia
  • Monash Children's Hospital Melbourne, Australia
  • Royal Childrens Hospital Melbourne, Australia
View all 68 locations
View Trial Details
Active, Not Recruiting

Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM

NCT07150104

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Salvador, Estado de Bahia, Brazil
  • GSK Investigational Site Porto Alegre, Rio Grande do Sul, Brazil
  • GSK Investigational Site Halifax, Nova Scotia, Canada
  • GSK Investigational Site Villejuif, France
View Trial Details
Active, Not Recruiting

Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM

NCT07217184

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Atlanta, Georgia, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Grand Rapids, Michigan, United States
  • GSK Investigational Site Madison, Wisconsin, United States
View all 19 locations
View Trial Details

Related conditions